Tolerance of granulocyte donors towards granulocyte colony-stimulating factor stimulation and of patients towards granulocyte transfusions: results of a multicentre study
- PMID: 14633259
- DOI: 10.1111/j.0042-9007.2003.00373.x
Tolerance of granulocyte donors towards granulocyte colony-stimulating factor stimulation and of patients towards granulocyte transfusions: results of a multicentre study
Abstract
Data of 507 granulocyte donations from 183 donors were evaluated. No severe granulocyte colony-stimulating factor (G-CSF)-related side-effects were observed. Three donors complained of severe itching following infusion of hydroxyethyl starch (HES). A high proportion (85%) of the donors stated that they would donate granulocytes again. The mean granulocyte yield was 4.3 x 10(10). High-molecular-weight HES resulted in a significantly higher yield compared with low-molecular-weight HES. Mild, but no severe, adverse transfusion reactions were observed in 16% of the recipients. A leucocyte alloimmunization rate of 24% was found. G-CSF stimulation and transfusion of G-CSF-mobilized granulocytes were well tolerated by donors and recipients, respectively.
Similar articles
-
Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation.Blood. 2000 Jun 1;95(11):3605-12. Blood. 2000. PMID: 10828051
-
Eighteen years experience of granulocyte donations-acceptable donor safety?J Clin Apher. 2015 Oct;30(5):265-72. doi: 10.1002/jca.21373. Epub 2014 Dec 26. J Clin Apher. 2015. PMID: 25546372
-
Effects of granulocyte-colony-stimulating factor on potential normal granulocyte donors.Transfusion. 1999 Oct;39(10):1136-40. doi: 10.1046/j.1537-2995.1999.39101136.x. Transfusion. 1999. PMID: 10532609 Clinical Trial.
-
Granulocyte transfusion in the G-CSF era.Int J Hematol. 2002 Aug;76 Suppl 2:77-80. doi: 10.1007/BF03165092. Int J Hematol. 2002. PMID: 12430904 Review.
-
Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions.Curr Opin Hematol. 1998 Nov;5(6):391-5. doi: 10.1097/00062752-199811000-00007. Curr Opin Hematol. 1998. PMID: 9814645 Review.
Cited by
-
Granulocyte collection by polymorphonuclear cell-targeting apheresis with medium-molecular-weight hydroxyethyl starch.Int J Hematol. 2021 Dec;114(6):691-700. doi: 10.1007/s12185-021-03207-6. Epub 2021 Aug 28. Int J Hematol. 2021. PMID: 34453685
-
Successful granulocyte apheresis using medium molecular weight hydroxyethyl starch.Int J Hematol. 2019 Dec;110(6):729-735. doi: 10.1007/s12185-019-02755-2. Epub 2019 Oct 10. Int J Hematol. 2019. PMID: 31602571
-
Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction.Cochrane Database Syst Rev. 2016 Apr 29;4(4):CD005339. doi: 10.1002/14651858.CD005339.pub2. Cochrane Database Syst Rev. 2016. PMID: 27128488 Free PMC article.
-
Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone.Transfusion. 2009 Mar;49(3):513-8. doi: 10.1111/j.1537-2995.2008.01983.x. Transfusion. 2009. PMID: 19243544 Free PMC article.
-
Guidelines for safety management of granulocyte transfusion in Japan.Int J Hematol. 2010 Mar;91(2):201-8. doi: 10.1007/s12185-010-0506-z. Epub 2010 Feb 11. Int J Hematol. 2010. PMID: 20146029
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical